FDA Inspection 941193 — Direct Rx

Direct Rx — FEI 3011690045

The FDA completed an inspection of Direct Rx on August 13, 2015 in Dawsonville, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 13, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dawsonville, GA (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
200921 CFR 211.188Prepared for each batch, include complete information
434021 CFR 211.142Written warehousing procedures established/followed